Elke Janssens focuses on corporate law, public and private M&A, corporate governance issues and equity capital markets. Her background in both law and economics is highly appreciated in M&A transactions. Thanks to her academic background, Elke is skilled at coming up with creative solutions to her clients' problems at short notice. She advises both listed and unlisted companies and is regularly involved in restructuring transactions, as well.
Recently, Elke advised on R&S's public takeover bid for the FNG Group NV (2017), the incorporation of Aelin Therapeutics by an international investor group (late 2017), Sanofi's takeover bid for Ablynx (2018) and the capital round of, among others, ConfoTherapeutics, EyeD, Settlemint, Imcyse, Augustine Therapeutics (2019).
Elke received her law degree from the Vrije Universiteit Brussel (VUB) in 1996. In 1998, she obtained an LL.M in business law from the Université Libre de Bruxelles (ULB), followed by a master's in management from VUB in 2001. She also completed coursework in the Solvay Business School's MBA programme in 2006-2007. Elke is trained as a compliance offer (UCL, 2016) and yoga teacher (2017).
Elke is the author of numerous publications in the fields of corporate and financial law and was a driving force in the VUB's Business Law Department for many years.